Examining validity and precision of prognostic models. - PowerPoint PPT Presentation

1 / 32
About This Presentation
Title:

Examining validity and precision of prognostic models.

Description:

Examining validity and precision of prognostic models. Dan McGee. Department of Statistics ... The National Heart, Lung, and Blood Institute. Funding: HL67640 ... – PowerPoint PPT presentation

Number of Views:13
Avg rating:3.0/5.0
Slides: 33
Provided by: danm68
Category:

less

Transcript and Presenter's Notes

Title: Examining validity and precision of prognostic models.


1
Examining validity and precision of prognostic
models.
  • Dan McGee
  • Department of Statistics
  • Florida State University
  • dan_at_stat.fsu.edu

2
Acknowledgements
  • The National Heart, Lung, and Blood Institute.
    Funding HL67640
  • The Diverse Populations Collaboration

3
  • Validity
  • Classification Efficacy
  • Predictive Accuracy

4
DPC Collaborating Centres
SCOTLAND 2 cohorts gt22,000 participants
ICELAND 1 cohort gt18,000 participants
USA 15 cohorts gt230,000 participants
CHINA 1 cohort gt7,000 participants
NORWAY 1 cohort gt48,000 participants
Hawaii 1 cohort gt8,000 participants
DENMARK 1 cohort gt10,000 participants
ISRAEL 4 cohorts gt35,000 participants
PUERTO RICO 1 cohort gt9,000 participants
YUGOSLAVIA 1 cohort gt6,000 participants
5
  • 21 Studies
  • 49 strata (gender, race, etc.)
  • 50 CVD deaths (within 10 years)in each strata
  • 219,973 Observations
  • 78,980 Female
  • 9,938 CVD deaths (within 10 years)

6
(No Transcript)
7
(No Transcript)
8
Age, age2, Log(age), Log(age/74) Cholesterol,
Log(chol/hdl) SBP, hypotensives, Diabetes,
Smoker Hypot.SBP, Cholage, LVH-ECG, Atrial
Fibrillation
9
Predict CVD death (10 years) based
on Age Systolic blood pressure Serum
cholesterol Diabetic status Smoking status
(yes/no)
10
Altman D and Royston P What do we mean
byvalidating a prognostic model? Statist Med
200019453-473.
  • Inform patients and their families.
  • Create clinical risk groups for stratification.
  • Inform treatment or other decisions for
    individual patients.
  • Usefulness is determined by how well a model
    works in practice.

11
High CVD risk regions, risk based on total
cholesterol
12
Low CVD risk regions, risk based on total
cholesterol
13
Reliable classification of patients into
different groups with different prognosis.
Area under the Receiver Operator Characteristic
Curve c-statistic, statistic of concordance.
14
Receiver Operating Characteristic (ROC) analysis
15
(No Transcript)
16
Random effects summary .79 (.77,.81)
17
(No Transcript)
18
(No Transcript)
19
Random effects summary .71 (.70, .73)
20
(No Transcript)
21
(No Transcript)
22
Classification Model (Gordon 1979) Each person
belongs to either one group or another. Estimated
probabilities tend to be a unimodal right-skewed
distribution.
23
(No Transcript)
24
How close are the estimated probabilities to the
observed values.
Predictive Accuracy Goodness of Fit Explained
Variation Strength of association R2
25
Ordinary Least Squares (OLS) R2 Coefficient of
determination Explained variance Squared
correlation, observed, predicted
26
Average .095
27
Gordon (1979)
28
(No Transcript)
29
The error sum of squares is the only reasonable
criteria for judging residual variation in OLS.
(Efron 1978)
Several exist for dichotomous dependent variables.
30
(Menard 2000)
31
Average .16
32
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com